Polpharma S.A. - Strategic SWOT Spotlight is a comprehensive and easily accessible overview of The Polpharma S.A.'s business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, Competitive Landscape and latest events.
Key Highlights
Polpharma S.A. is a pharmaceutical company that operates in Poland. They offer a wide range of products and services in the healthcare industry. Their offerings include prescription and over-the-counter medications, as well as medical devices and dietary supplements. They also provide contract manufacturing services for other pharmaceutical companies. In addition, Polpharma S.A. offers research and development services, as well as clinical trials for new drugs. They are committed to providing high-quality and affordable healthcare solutions to improve the lives of patients. With a strong focus on innovation and continuous improvement, Polpharma S.A. is a trusted and reliable partner in the healthcare industry. Founded in 1935, the company is headquartered in Starogard, Pomeranian, Poland.
Polpharma S.A. in the News:-
01-Mar-2024 - MERGER OF COMPANIES
15-Oct-2023 - Polpharma's new kilo-scale development and production laboratory is up and running
04-Jul-2023 - Polpharma received EcoVadis Silver Medal
16-Jun-2023 - Polpharma received Golden CSR Leaf for the 9th time
31-May-2023 - Most Attractive Employers Poland 2023: Polpharma on the podium of the ranking in the category of Exact Sciences
Scope
Company Fundamentals:- These fundamentals offer valuable insights into Polpharma S.A.'s operations, geographical presence, products and services, ESG spotlight, Corporate Strategy, Business Description and SWOT spotlight, aiding in a comprehensive understanding of the organization.
Reasons to Buy
Helicopter view of company's internal and external factors through SWOT analysis - Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers. - Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations. - Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Table of Contents
Tables
Charts
Polpharma S.A. - Key Company Facts
Polpharma S.A. - Company Description
Polpharma S.A. - Top Executives
Polpharma S.A. - Head Office & Locations
Head Office - Country
Polpharma S.A. - Products and Services
Products
Services
Polpharma S.A. - Corporate Strategy
Polpharma S.A. - Business Description
Pharmaceutical Manufacturing
Active Pharmaceutical Ingredients (APIs) Manufacturing
Polpharma S.A. - ESG Spotlight
Environment
Social
Corporate Governance
Polpharma S.A. - SWOT Spotlight
Overview
Strengths
Weaknesses
Opportunities
Threats
Competing Players
Snapshot of Competing Players
GSK plc
Key Company Facts
Company Description
Key Financials:
Novartis AG
Key Company Facts
Company Description
Key Financials:
Pfizer Inc.
Key Company Facts
Company Description
Key Financials:
Sanofi SA
Key Company Facts
Company Description
Key Financials:
Teva Pharmaceutical Industries Limited
Key Company Facts
Company Description
Key Financials:
Polpharma S.A. - In the News
01-Mar-2024- MERGER OF COMPANIES
15-Oct-2023- Polpharma's new kilo-scale development and production laboratory is up and running
04-Jul-2023- Polpharma received EcoVadis Silver Medal
16-Jun-2023- Polpharma received Golden CSR Leaf for the 9th time
31-May-2023- Most Attractive Employers Poland 2023: Polpharma on the podium of the ranking in the category of Exact Sciences